By Digifin Pty Ltd · About this coverage
Key Points
- Three-year exclusive Felix deal with INVIDO for CZ, SK and Kazakhstan
- Minimum purchases €416,200 (~A$674,000) over three years
- Year 1 ~A$139,000 rising to ~A$310,000 in Year 3
- Addressable ~89,600 ART cycles across the three territories
- Arne Schierau appointed Director, Commercial Operations Europe
About Memphasys (ASX:MEM)
Memphasys Limited is an ASX-listed reproductive biotechnology company headquartered in Homebush West, New South Wales. It commercialises the Felix System, a sperm-selection technology for human assisted reproduction sold through direct and distributor channels.
Memphasys (ASX:MEM) has signed a three-year exclusive commercial distribution agreement with INVIDO LAB for its Felix System covering the Czech Republic, Slovakia and Kazakhstan, expanding its European footprint and installing dedicated regional commercial support.
Minimum contracted purchases total €416,200 (approximately A$674,000) over the initial three-year term, rising from €86,000 (about A$139,000) in Year 1 to €138,600 (about A$225,000) in Year 2 and €191,600 (about A$310,000) in Year 3, converted at €1.00 = A$1.62 as at 16 September 2026. INVIDO has exclusivity for Felix cartridges and consoles across those territories subject to agreed minimum purchase and other commercial performance requirements, and will lead commercial development with Memphasys' European team. The company cites a combined addressable market of about 89,600 ART cycles across the contracted territories, including about 54,300 in the Czech Republic, 8,288 in Slovakia and 27,012 in Kazakhstan, which also supports 7,000 publicly funded IVF/ICSI treatment quotas annually. Arne Schierau has been appointed Director, Commercial Operations Europe.
Australian dollar amounts are approximate and may vary with exchange rates at payment, and further international partner discussions are not yet concluded.
Source: Memphasys Limited (ASX:MEM), 18 September 2026. Summary content supplied by Digifin Pty Ltd.
News summary only, not financial advice. It does not consider your objectives, financial situation or needs.